Home
About
Back
About
Meet the Team
Back
Senior Leadership
Board of Directors
Scientific Advisory Board
Personalized Cancer Vaccine Clinical Advisor
History of Providence
Foundations of Providence
Technology
Back
mRNA Medicines Ecosystem
mRNA Medicines Platform
Next-Gen LNP
Validated Manufacturing
Pipeline
Business Development
Back
Partnerships
Funders
Investors
News & Media
Back
Press Releases
Publications
Media
Careers & Culture
Contact
Careers & Culture
Contact
Home
About
About
Meet the Team
Senior Leadership
Board of Directors
Scientific Advisory Board
Personalized Cancer Vaccine Clinical Advisor
History of Providence
Foundations of Providence
Technology
mRNA Medicines Ecosystem
mRNA Medicines Platform
Next-Gen LNP
Validated Manufacturing
Pipeline
Business Development
Partnerships
Funders
Investors
News & Media
Press Releases
Publications
Media
Careers & Culture
Contact
Media
After matching Comirnaty, Providence plans phase 3 booster study
Written on
October 26, 2022
Read more
Calgary-based Providence Therapeutics recruits for vaccine trial, secures funding for bringing jabs to developing world
Written on
December 29, 2021
Read more
Providence’s COVID-19 mRNA Vaccine Challenger Seen In Phase III In Q1
Written on
October 07, 2021
Read more
